Idelvion Kit
Product Images NDC 69911-866

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Idelvion (NDC 69911-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Lengnau Ag, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Idelvion 01)

An instructional diagram showing a vial adapter device, designed to connect a vial with other components for medication preparation or administration. The illustration depicts a cylindrical adapter with a circular top featuring a central hole.*

FDA Label Image

Figure 2 (Idelvion 02)

An instructional illustration showing a vial below a cylindrical cap with a downward arrow, indicating the direction to place or remove the cap from the vial. The image is likely part of a usage or preparation guide for the IDELVION coagulation factor IX recombinant human kit by CSL Behring Lengnau AG.*

FDA Label Image

Figure 3 (Idelvion 03)

An illustration showing the assembly of a medication vial and a mixing device or adapter, with an arrow indicating the direction to secure or connect the components. This is likely part of a preparation or reconstitution instruction for a drug kit.*

FDA Label Image

Figure 4 (Idelvion 04)

An instructional illustration showing a vial and a component above it with a downward arrow indicating the component is to be attached or inserted onto the vial. This likely depicts part of the assembly or preparation process for a drug product kit.*

FDA Label Image

Figure 5 (Idelvion 05)

An instructional illustration showing a vial attached to a stopper or adapter, likely demonstrating assembly or use steps for the IDELVION coagulation factor IX recombinant human kit by CSL Behring Lengnau AG.*

FDA Label Image

Figure 6 (Idelvion 06)

An instructional illustration showing a vial setup procedure for mixing or activating medication. The diagram depicts aligning and twisting the cap from one container onto the other, indicating the initial step in preparing a kit, likely related to IDELVION, a recombinant coagulation factor IX product.*

FDA Label Image

Figure 7 (Idelvion 07)

An instructional illustration showing a step in assembling or using a medical infusion device. The image depicts two connected cylindrical parts with alignment features and an arrow indicating a downward motion. This is likely part of the assembly or activation process for a kit component.*

FDA Label Image

Figure 8 (Idelvion 08)

An instructional illustration depicting the assembly of a syringe with a vial adapter. The image shows the syringe being connected to the top of a vial or container, with an arrow indicating a clockwise twist to secure the attachment.*

FDA Label Image

Figure 1 (Idelvion 09)

An illustration showing a hollow cylindrical device with a flared top edge and an inner circular opening. The image appears to depict a component that could be part of a kit, possibly a vial adapter or a similar accessory.*

FDA Label Image

Figure 2 (Idelvion 10)

An instructional illustration showing a vial and a mixing container positioned above it with a downward arrow indicating the direction to insert or connect the mixing container to the vial. This image likely demonstrates part of the preparation or reconstitution process for IDELVION (Coagulation Factor IX Recombinant Human) kit by CSL Behring Lengnau AG.*

FDA Label Image

Figure 3 (Idelvion 11)

An instructional illustration showing the assembly of a medical vial and a cap or stopper with an arrow indicating the direction to place or remove the cap. The image is a line drawing with no visible text or labels.*

FDA Label Image

Figure 4 (Idelvion 12)

An instructional illustration showing assembly steps for the IDELVION Coagulation Factor IX Recombinant Human KIT. The diagram depicts attaching a component to a vial with directional arrows indicating the joining process.*

FDA Label Image

Figure 5 (Idelvion 13)

IDEALVION kit by CSL Behring Lengnau AG shown as a line drawing of a vial and stopper. The image depicts the medication's container components used for the coagulant factor IX recombinant human plasma derivative.*

FDA Label Image

Figure 6 (Idelvion 14)

An instructional line drawing illustrating how to connect or assemble two components of a medical kit. The image shows a top component being rotated clockwise to attach to a bottom component, suggesting a twist-lock mechanism. The components appear cylindrical with detailed fastening elements.*

FDA Label Image

Figure 7 (Idelvion 15)

An instructional illustration showing the assembly step of a syringe, with a focus on connecting or securing components. A downward arrow indicates the direction to push or attach parts together.*

FDA Label Image

Figure 8 (Idelvion 16)

An instructional illustration showing the components of a KIT, depicting a bottle being connected or assembled to a syringe or vial, with an arrow indicating the direction of connection or assembly.*

FDA Label Image

Principal Display Panel (250 IU Range Kit Carton)

IDEVION 250 IU kit packaging label featuring Coagulation Factor IX (Recombinant), Albumin Fusion Protein. The label includes dosing information, storage instructions, manufacturer details (CSL Behring GmbH, Germany), and distributor information (CSL Behring LLC, USA). The kit contains a single-dose vial of lyophilized powder for intravenous reconstitution and administration.*

FDA Label Image

Principal Display Panel (500 IU Range Kit Carton)

IDEVLION 500 IU Range KIT containing Coagulation Factor IX (Recombinant), Albumin Fusion Protein. The packaging includes product and manufacturer details by CSL Behring GmbH and CSL Behring Lengnau AG. It shows storage instructions, lot and expiration placeholders, and notes the product is for intravenous administration only. The kit consists of a lyophilized powder vial and accompanying reconstitution solution.*

FDA Label Image

Principal Display Panel (1000 IU Range Kit Carton)

The packaging label for IDELVION 1000 IU Range kit features Coagulation Factor IX (Recombinant), Albumin Fusion Protein in a single-dose vial with lyophilized powder for reconstitution. The label includes manufacturer CSL Behring GmbH in Germany, distributor CSL Behring LLC in the USA, storage instructions at 2-25°C, barcode, and detailed product information including contents and lot numbers.*

FDA Label Image

Principal Display Panel (2000 IU Range Kit Carton)

The packaging label for IDELVION 2000 IU Range, a kit containing Coagulation Factor IX (Recombinant), Albumin Fusion Protein. The label includes details such as lyophilized powder for reconstitution, intravenous administration only, manufacturing and distribution information by CSL Behring GmbH and CSL Behring Lengnau AG, storage instructions at 2-25°C, and a list of components including sterile water for injection and sodium citrate. The label displays the NDC 69911-867-02 and emphasizes it is a plasma derivative.*

FDA Label Image

Idelvion 21

Packaging label for IDELVION 3500 IU range, a kit containing Coagulation Factor IX (Recombinant), Albumin Fusion Protein. The label includes usage indication for intravenous administration only, manufacturer CSL Behring GmbH, and distributor CSL Behring LLC. The label notes storage instructions and contents including a single-dose vial with lyophilized powder for reconstitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.